B.J. Stevenson

Discipline

Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (21) Recensions (1)

Co-auteur

Date

Source

Mot-clé

cancer (12) Cancer (12) Cancer (12) Genes (9) analyse (8) Human beings (8) Expression (8) Analysis (8) gène (7) Identification (7) Tumors (7) Patients (7) Identification (7) Identification (7) Patients (7) Cells (6) Tumors (6) Number (6) T cells (5) Immunotherapy (5) Antigens (5) Immunotherapy (5) Control (4) Strategy (4) Mice (4) Gene expression (4) Cancer--Patients (4) Animals (4) roman (4) tissu (corporel) (3)

Documents écrit par B.J. Stevenson (21) | parle de B.J. Stevenson (0)

The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer.
A.I. Kraemer et al.
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity.
H. Fritah et al. (21 avr. 2023)
Sensitive identification of neoantigens and cognate TCRs in human solid tumors.
M. Arnaud et al.
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING.
M. Bruand et al. (20 juil. 2021)
Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
J.L. Tanyi et al. (4 mai 2021)
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
J.L. Tanyi et al. (15 mars 2021)
CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens.
G. Forlani et al. (2021)
Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction.
H. Pak et al. (2021)
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma.
A. Sarivalasis et al. (26 nov. 2019)
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.
A. Newey et al. (18 nov. 2019)
Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures.
D. Cassatella et al.
Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer.
S. Bobisse et al. (15 mars 2018)
RNAseq analysis of heart tissue from mice treated with atenolol and isoproterenol reveals a reciprocal transcriptional response.
A. Prunotto et al. (2016)
Angiogenic activity of breast cancer patients' monocytes reverted by combined use of systems modeling and experimental approaches.
N. Guex et al. (2015)
Assessment of transcript reconstruction methods for RNA-seq.
T. Steijger et al. (2013)
Identification and validation of copy number variants using SNP genotyping arrays from a large clinical cohort.
A. Valsesia et al. (2012)
Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.
A. Valsesia et al. (2011)
Frequent MAGE mutations in human melanoma.
O.L. Caballero et al. (2010)
AssociationViewer: a scalable and integrated software tool for visualization of large-scale variation data in genomic context.
O. Martin et al. (2009)
Rapid evolution of cancer/testis genes on the X chromosome.
B.J. Stevenson et al. (2007)
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.
A. Grigoriadis et al. (2006)